Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says Drug Candidates Passed On-Site Inspection For Drug Registration In China

Sept 13 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * ADAPALENE CLINDAMYCIN HYDROCHLORIDE COMBINATION GEL
PASSING
ON-SITE INSPECTION FOR DRUG REGISTRATION IN CHINA BY NMPA

Source text for Eikon:  ID:nHKSbRQ1gN 
Further company coverage:  6622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news